Bank of New York Mellon’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Bank of New York Mellon’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-43,341	Closed	-$101K	–	4331
2019 Q1	$101K	Sell	43,341 -286	-0.7%	-$775	﹤0.01%	4001
2018 Q4	$101K	Hold	43,627	–	–	﹤0.01%	3958
2018 Q3	$647K	Buy	43,627 +6,682	+18%	+$106K	﹤0.01%	3513
2018 Q2	$561K	Buy	36,945 +4,956	+15%	+$84.1K	﹤0.01%	3585
2018 Q1	$601K	Buy	31,989 +16,508	+107%	+$289K	﹤0.01%	3490
2017 Q4	$281K	Buy	15,481 +3,144	+25%	+$66.5K	﹤0.01%	3832
2017 Q3	$274K	Buy	+12,337	New	+$271K	﹤0.01%	3782

Other funds holding SNNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon's SNNA Position: Q2 2019 in Review

Bank of New York Mellon sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q2 2019, closing a stake of 43,341 shares — an estimated $101K sold.

Bank of New York Mellon first reported a position in SNNA in Q3 2017 and held it in 7 quarters. The position peaked at $647K in Q3 2018. 48 funds tracked by Wall St. Rank hold SNNA as of Q2 2019.

Bank of New York Mellon reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Bank of New York Mellon sold 43,341 Sienna Biopharmaceuticals, Inc. shares in Q2 2019, an estimated $101K.
Bank of New York Mellon first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and held it in 7 quarters.
Bank of New York Mellon's Sienna Biopharmaceuticals, Inc. position peaked at $647K in Q3 2018.
48 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q2 2019.

Based on Bank of New York Mellon's 13F filing for Q2 2019, filed 12 Aug 2019.